For instance, Apolipoprotein E (APOE)-ɛ4, one of the major risk factors for SAD, is known to regulate the metabolism of Aβ contributing to Aβ depositions in the brain; yet the correlation of APOE-ɛ4 and AD progression is still controversial [105]. Here, APOE is linked to Alzheimer disease.